Study on stability of cefepime in peritoneal dialysis solution Clinical Efficacy of Cefepime for Hospital Acquired Pneumonia in Senile Patients

Effect of 4.25% peritoneal dialysis solution on CD40 expression in rat peritoneal mesothelial cells

腹透液增强腹膜间皮细胞CD40表达及其意义

Effects of peritoneal dialysis solution on proliferation and apoptosis of rat peritoneal mesothelial cells

腹透液对大鼠腹膜间皮细胞凋亡和增殖的影响

Effect of different peritoneal dialysis solution on tight junctions of peritoneal mesothelial cell

不同含糖浓度腹透液对腹膜细胞紧密连接影响的实验研究

Inhibition effect of Puerarin on the formation of advanced glycosylation end products in peritoneal dialysis solution in vitro

葛根素抑制葡萄糖腹膜透析液中糖基化终末产物形成的体外研究

Experimental study on emergency treatment with cool peritoneal dialysis solution lavage in heatstroke shock model

冷腹膜透析液腹腔灌洗抢救热射病休克的实验研究

Comparison of copper accumulation in fish and dialysis membrane

养鱼污水中鱼和树脂-半透膜囊对铜吸收的对比研究

Influence of the different dialysis membrane on the interleukin-8 expression

使用不同透析膜时IL-8表达的改变

Dielectric Analysis of Dialysis Membrane/ Solution System under DC Bias Voltage Application

直流偏压下透折膜/水溶液体系的介电解析

The separation of scandium and tin by chitin dialysis membrane

甲壳素渗析膜分离钪锡

After dialysis therapy, the plasma amino acid concentrations might still be abnormal.

透析治疗后，氨基酸谱可能仍为异常。血浆游离DNA；

Comparison of Clinical Analysis of Different Dialysis Therapy in Elderly Patients with Uremia

不同透析方式治疗老年尿毒症的临床对比分析

The current researches in modern medical condition are dialysis therapy, kidney transplantation, gene therapy, and so on.

现代医学部份阐述目前的研究状况，如透析疗法，肾移植，基因等疗法。

Clinical Study of Dialysis Therapy in Older Patients with Chronic Renal Failure

老年慢性肾衰透析疗法的临床观察

Result: The ultrafiltration rate, dialysate electrolyte concentration, dialysate temperature and blood pressure levels prior to dialysis were similar during pre and post midodrine administration periods ( p> 0.05).

结果：16例192例次米多君治疗患者血液透析中脱水速度，透析液电解质浓度，透析温度及透析前血压均无显著性差异（p>0.05）；

Objective: To investigate the change of serum sodium activity and blood pressure during variable-sodium dialysis ( VSD) and standard-sodium dialysis ( SSD).

目的：探讨可变钠碳酸氢盐与标准钠碳酸氢盐透析时血清钠活性的变化以及对血压的影响。

The relation between the composition and osmotic pressure of peritoneal dialysis solutions produced by three pharmaceutical factories and the clinical effects was evaluated.

本文对三个厂家生产的腹膜透析液的成份、渗透压等制剂因素与临床疗效的关系进行了分析探讨。

Objective To evaluate the therapeutic effects of dialysis regimen for multiple organ dysfunction syndrome ( MODS) due to fish gall bladder poisoning.

目的探讨口服生鱼胆致多器官功能障碍综合征（MODS）的临床治疗。

Conclusion The main factors of origin in HA-ARF are infection, cardial and cerebrovascular disease, acute hypovolemia and operation. The mortality rate of this disease is higher. Etilogical treatment promptly and dialysis regimen are the main means to rescue these patients.

结论HA-ARF的主要病因是感染、心脑血管疾病、急性血容量减少和大手术，其死亡率较高，积极进行病因治疗和透析疗法是抢救患者的主要手段。

The second, the permeation rate was decreased because the increased viscosity and surface tension formed a liquid membrane in the surface of dialysis bag to enlarge the unstirred layer and the concentration polarization phenomenon.

溶胶黏度和表面张力较大，能在介质表面形成液膜，增大了介质表面非搅动层的厚度和浓差极化现象，使透过速率下降；

The high degree of substitution product was purified and graded with dialysis bag. Two kinds of sulfated agarose ( AGS) with different molecular weights were obtained.

对于高取代度产物，通过透析纯化分级，获得两种不同分子量分布的琼脂糖硫酸酯（AGS）。